FARALLON PARTNERS L L C/CA Insider Trading Activity

Average Profitability
6.59%
Insider Buys Quantity
3
Insider Buys Sum
$93.69M
Insider Sells Quantity
6
Insider Sells Sum
$325.43M

Insider Activity of FARALLON PARTNERS L L C/CA

According to the SEC Form 4 filings, FARALLON PARTNERS L L C/CA, being in a position of

  1. Member of a Group Owning 10% at Lantheus Holdings, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 3406000 shares for $191.21M,
    over all time since 2025-08-19, has bought 0 shares, and sold 3406000 shares for $191.21M.

Biography of FARALLON PARTNERS L L C/CA

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $191,213,6902100

Comparison of Insiders on Amount of Buys and Sells

2025-11-14PurchaseACV Auctions Inc.
ACVA
director
80,571
0.0456%
$6.21$500,346+0.48%
2025-11-14SaleAkamai Technologies, Inc.
AKAM
Chief Technology Officer
3,000
0.0021%
$87.68$263,051-0.59%
2025-11-14SaleApogee Therapeutics, Inc.
APGE
Chief Financial Officer
2,000
0.0038%
$65.00$130,000+0.77%
2025-11-14SaleAppFolio, Inc.
APPF
General Counsel
334
0.0009%
$243.67$81,386+1.76%
2025-11-14SaleArlo Technologies, Inc.
ARLO
GENERAL COUNSEL
149,521
0.1385%
$14.37$2.15M-1.62%
2025-11-14SaleBKV Corporation
BKV
Chief Executive Officer
21,719
0.027%
$28.00$608,202-0.19%
2025-11-14PurchaseCenturi Holdings, Inc.
CTRI
10 percent owner
3.49M
4.0403%
$21.50$75M-2.93%
2025-11-14PurchaseCVB Financial Corp.
CVBF
director
27,094
0.0195%
$18.45$499,995+2.2%
2025-11-14SaleDraftKings Inc.
DKNG
Chief Financial Officer
8,421
0.0017%
$29.23$246,146+1.2%
2025-11-14SaleDianthus Therapeutics, Inc.
DNTH
EVP, Head of R&D
109,031
0.3235%
$38.14$4.16M+7.11%
2025-11-14PurchaseThe Eastern Company
EML
director
762
0.0122%
$19.47$14,836+0.1%
2025-11-14SaleEntravision Communications Corporation
EVC
10 percent owner
46,064
0.0491%
$2.77$127,491+2.97%
2025-11-14PurchaseFTAI Aviation Ltd.
FTAI
Chief Financial Officer
652
0.0006%
$153.46$100,056+3.15%
2025-11-14PurchaseFirst US Bancshares, Inc.
FUSB
director
500
0.0083%
$13.43$6,715-0.15%
2025-11-14SaleGigaCloud Technology Inc.
GCT
Chief Operating Officer
30,000
0.0787%
$30.42$912,597+<0.01%
2025-11-14SaleJanux Therapeutics, Inc.
JANX
Chief Business Officer
3,333
0.0061%
$30.00$99,990-2.4%
2025-11-14SaleKura Oncology, Inc.
KURA
Chief Operating Officer
6,902
0.0083%
$11.18$77,143+0.25%
2025-11-14SaleKura Oncology, Inc.
KURA
SVP, Finance & Accounting
4,539
0.0055%
$11.18$50,732+0.25%
2025-11-14SaleKura Oncology, Inc.
KURA
Chief Commercial Officer
8,887
0.0107%
$11.18$99,329+0.25%
2025-11-14SaleKura Oncology, Inc.
KURA
Chief Legal Officer
8,804
0.0106%
$11.18$98,401+0.25%
Total: 828943
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.